ondansetron has been researched along with Headache Disorders in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42." | 8.89 | Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013) |
| "The merged early incidence of postoperative nausea and vomiting (PONV) in ondansetron group (42." | 4.89 | Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis. ( Cheng, NS; Lin, YX; Wu, SJ; Xiong, XZ, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, SJ | 1 |
| Xiong, XZ | 1 |
| Lin, YX | 1 |
| Cheng, NS | 1 |
1 review available for ondansetron and Headache Disorders
| Article | Year |
|---|---|
Comparison of the efficacy of ondansetron and granisetron to prevent postoperative nausea and vomiting after laparoscopic cholecystectomy: a systematic review and meta-analysis.
Topics: Antiemetics; Cholecystectomy, Laparoscopic; Granisetron; Headache Disorders; Humans; Ondansetron; Po | 2013 |